Whole Slide Imaging Market Report
Description
The global whole slide imaging market size reached USD 933.2 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 2,156.0 Million by 2034, exhibiting a growth rate (CAGR) of 9.46% during 2026-2034.
Whole slide imaging (WSI) is scanning glass slides used to produce high-resolution and precise digital images of tissue sections. It comprises a focusing unit, camera, illumination systems, scanners, viewers, image management system, and microscopic optical components. WSI utilizes a specialized scanner to digitize glass slides and generate large digital images that are analyzed, stored, and shared through the virtual slide viewer. It is widely used in immunohistochemistry, telepathology, hematopathology, and cytopathology. WSI assists in improving accuracy, speed of analysis, increasing productivity, reducing errors, and providing reliable and convenient results. As a result, it is widely used across academic and research institutes, biotechnology and pharmaceutical companies, and hospitals and clinics.
WHOLE SLIDE IMAGING MARKET TRENDS:
The significant growth in the healthcare industry and the rising focus on patient safety across the globe are the prime factors creating a positive outlook for the market. Additionally, the rising prevalence of cancer due to the changing lifestyles, genetic mutation, and increasing smoking and alcohol habits is favoring the market growth. In line with this, WSI is extensively used in diagnostic procedures for suspected skin, lungs, and breast cancer, which is further providing an impetus to the market growth. Moreover, various technological advancements, such as the integration of artificial intelligence (AI) and machine learning (ML) to assist in various diseases and diagnoses and provide precision medicine delivery, are providing a considerable boost to the market growth. In line with this, the widespread adoption of whole slide imaging in immunohistochemistry (IHC) to observe protein expression in tissue samples and detect antigens in the cells is positively impacting the market growth. Other factors, such as the increasing product demand in drug discovery and extensive research and development (R&D) activities, are anticipated to drive the market growth.
KEY MARKET SEGMENTATION:
IMARC Group provides an analysis of the key trends in each sub-segment of the global whole slide imaging market report, along with forecasts at the global, regional and country level from 2026-2034. Our report has categorized the market based on technology, application and end user.
Breakup by Technology:
Canada
Japan
India
South Korea
Australia
Indonesia
Others
France
United Kingdom
Italy
Spain
Russia
Others
Mexico
Others
The report provides a comprehensive analysis of the competitive landscape in the global whole slide imaging market with detailed profiles of all major companies, including:
1. How big is the whole slide imaging market?
2. What is the future outlook of whole slide imaging market?
3. What are the key factors driving the whole slide imaging market?
4. Which region accounts for the largest whole slide imaging market share?
5. Which are the leading companies in the global whole slide imaging market?
Whole slide imaging (WSI) is scanning glass slides used to produce high-resolution and precise digital images of tissue sections. It comprises a focusing unit, camera, illumination systems, scanners, viewers, image management system, and microscopic optical components. WSI utilizes a specialized scanner to digitize glass slides and generate large digital images that are analyzed, stored, and shared through the virtual slide viewer. It is widely used in immunohistochemistry, telepathology, hematopathology, and cytopathology. WSI assists in improving accuracy, speed of analysis, increasing productivity, reducing errors, and providing reliable and convenient results. As a result, it is widely used across academic and research institutes, biotechnology and pharmaceutical companies, and hospitals and clinics.
WHOLE SLIDE IMAGING MARKET TRENDS:
The significant growth in the healthcare industry and the rising focus on patient safety across the globe are the prime factors creating a positive outlook for the market. Additionally, the rising prevalence of cancer due to the changing lifestyles, genetic mutation, and increasing smoking and alcohol habits is favoring the market growth. In line with this, WSI is extensively used in diagnostic procedures for suspected skin, lungs, and breast cancer, which is further providing an impetus to the market growth. Moreover, various technological advancements, such as the integration of artificial intelligence (AI) and machine learning (ML) to assist in various diseases and diagnoses and provide precision medicine delivery, are providing a considerable boost to the market growth. In line with this, the widespread adoption of whole slide imaging in immunohistochemistry (IHC) to observe protein expression in tissue samples and detect antigens in the cells is positively impacting the market growth. Other factors, such as the increasing product demand in drug discovery and extensive research and development (R&D) activities, are anticipated to drive the market growth.
KEY MARKET SEGMENTATION:
IMARC Group provides an analysis of the key trends in each sub-segment of the global whole slide imaging market report, along with forecasts at the global, regional and country level from 2026-2034. Our report has categorized the market based on technology, application and end user.
Breakup by Technology:
- Scanners
- IT Infrastructure
- Viewer
- Image Management System
- Immunohistochemistry
- Telepathology
- Cytopathology
- Hematopathology
- Academic Institute
- Research
- Others
- North America
Canada
- Asia-Pacific
Japan
India
South Korea
Australia
Indonesia
Others
- Europe
France
United Kingdom
Italy
Spain
Russia
Others
- Latin America
Mexico
Others
- Middle East and Africa
The report provides a comprehensive analysis of the competitive landscape in the global whole slide imaging market with detailed profiles of all major companies, including:
- 3DHISTECH Ltd.
- Akoya Biosciences, Inc
- Evident Scientific
- F. Hoffmann-La Roche Ltd
- Hamamatsu Photonics K.K.
- Huron Technologies International Inc.
- Leica Biosystems
- Mikroscan Technologies, Inc.
- Motic Digital Pathology
- OptraSCAN Inc.
- Visiopharm A/S
1. How big is the whole slide imaging market?
2. What is the future outlook of whole slide imaging market?
3. What are the key factors driving the whole slide imaging market?
4. Which region accounts for the largest whole slide imaging market share?
5. Which are the leading companies in the global whole slide imaging market?
Table of Contents
135 Pages
- 1 Preface
- 2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
- 3 Executive Summary
- 4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
- 5 Global Whole Slide Imaging Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
- 6 Market Breakup by Technology
- 6.1 Scanners
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 IT Infrastructure
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Viewer
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Image Management System
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 7 Market Breakup by Application
- 7.1 Immunohistochemistry
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Telepathology
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Cytopathology
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Hematopathology
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 8 Market Breakup by End User
- 8.1 Academic Institute
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Research
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
- 10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
- 11 Value Chain Analysis
- 12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
- 13 Price Analysis
- 14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 3DHISTECH Ltd.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 Akoya Biosciences, Inc
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Evident Scientific
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 F. Hoffmann-La Roche Ltd
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.5 Hamamatsu Photonics K.K.
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Huron Technologies International Inc.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.7 Leica Biosystems
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Mikroscan Technologies, Inc.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.9 Motic Digital Pathology
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 OptraSCAN Inc.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 Visiopharm A/S
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
